Cargando…
Multidrug-resistant tuberculosis: diagnosis, checklists, adverse events, advice and outcomes
The account of MDR-TB in Finland describes current practice. Genetic testing of primary specimens, whole-genome sequencing, supportive directly observed therapy, checklists and national consilia will contribute to further improvements in managing MDR-TB. https://bit.ly/3rOnb3u
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703147/ https://www.ncbi.nlm.nih.gov/pubmed/36451839 http://dx.doi.org/10.1183/23120541.00512-2022 |
| _version_ | 1784839800009785344 |
|---|---|
| author | Bothamley, Graham H. |
| author_facet | Bothamley, Graham H. |
| author_sort | Bothamley, Graham H. |
| collection | PubMed |
| description | The account of MDR-TB in Finland describes current practice. Genetic testing of primary specimens, whole-genome sequencing, supportive directly observed therapy, checklists and national consilia will contribute to further improvements in managing MDR-TB. https://bit.ly/3rOnb3u |
| format | Online Article Text |
| id | pubmed-9703147 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | European Respiratory Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97031472022-11-29 Multidrug-resistant tuberculosis: diagnosis, checklists, adverse events, advice and outcomes Bothamley, Graham H. ERJ Open Res Editorials The account of MDR-TB in Finland describes current practice. Genetic testing of primary specimens, whole-genome sequencing, supportive directly observed therapy, checklists and national consilia will contribute to further improvements in managing MDR-TB. https://bit.ly/3rOnb3u European Respiratory Society 2022-11-28 /pmc/articles/PMC9703147/ /pubmed/36451839 http://dx.doi.org/10.1183/23120541.00512-2022 Text en Copyright ©The authors 2022 https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org) |
| spellingShingle | Editorials Bothamley, Graham H. Multidrug-resistant tuberculosis: diagnosis, checklists, adverse events, advice and outcomes |
| title | Multidrug-resistant tuberculosis: diagnosis, checklists, adverse events, advice and outcomes |
| title_full | Multidrug-resistant tuberculosis: diagnosis, checklists, adverse events, advice and outcomes |
| title_fullStr | Multidrug-resistant tuberculosis: diagnosis, checklists, adverse events, advice and outcomes |
| title_full_unstemmed | Multidrug-resistant tuberculosis: diagnosis, checklists, adverse events, advice and outcomes |
| title_short | Multidrug-resistant tuberculosis: diagnosis, checklists, adverse events, advice and outcomes |
| title_sort | multidrug-resistant tuberculosis: diagnosis, checklists, adverse events, advice and outcomes |
| topic | Editorials |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703147/ https://www.ncbi.nlm.nih.gov/pubmed/36451839 http://dx.doi.org/10.1183/23120541.00512-2022 |
| work_keys_str_mv | AT bothamleygrahamh multidrugresistanttuberculosisdiagnosischecklistsadverseeventsadviceandoutcomes |